EdgarLookup

TuHURA Biosciences, Inc./NV — Quarterly Financials

Quarterly figures from SEC EDGAR XBRL filings (10-Q)

These figures are extracted from XBRL-tagged quarterly reports (10-Q) that TuHURA Biosciences, Inc./NV filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.

Overview All Filings Annual Quarterly Insiders

Revenue — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2025 Sep 30, 2025 $0 Nov 14, 2025
Q2 2025 Jun 30, 2025 $0 Aug 14, 2025
Q1 2025 Mar 31, 2025 $0 May 15, 2025
Q3 2025 Sep 30, 2024 $0 Nov 14, 2025
Q2 2025 Jun 30, 2024 $0 Aug 14, 2025
Q1 2025 Mar 31, 2024 $0 May 15, 2025
Q2 2013 Dec 31, 2012 $0 Jan 18, 2013
Q1 2013 Sep 30, 2012 $0 Dec 20, 2012
Q3 2012 Mar 31, 2012 $0 Jun 5, 2012
Q2 2013 Dec 31, 2011 $0 Jan 18, 2013
Q1 2013 Sep 30, 2011 $0 Dec 20, 2012
Q3 2012 Mar 31, 2011 $0 Jun 5, 2012
Q2 2012 Dec 31, 2010 $0 Feb 7, 2012

Net Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2025 Sep 30, 2025 ($7.10M) Nov 14, 2025
Q2 2025 Jun 30, 2025 ($9.52M) Aug 14, 2025
Q3 2025 Jun 30, 2025 ($9.52M) Nov 14, 2025
Q3 2025 Mar 31, 2025 ($6.66M) Nov 14, 2025
Q1 2025 Mar 31, 2025 ($6.66M) May 15, 2025
Q2 2025 Mar 31, 2025 ($6.66M) Aug 14, 2025
Q3 2025 Sep 30, 2024 ($5.58M) Nov 14, 2025
Q1 2025 Sep 30, 2024 ($2.16M) Nov 14, 2024
Q2 2025 Jun 30, 2024 ($5.27M) Aug 14, 2025
Q3 2025 Jun 30, 2024 ($5.27M) Nov 14, 2025
Q2 2025 Mar 31, 2024 ($4.84M) Aug 14, 2025
Q3 2025 Mar 31, 2024 ($4.84M) Nov 14, 2025
Q1 2025 Mar 31, 2024 ($4.84M) May 15, 2025
Q2 2024 Dec 31, 2023 ($1.02M) Feb 14, 2024
Q1 2025 Sep 30, 2023 ($2.96M) Nov 14, 2024
Q3 2024 Mar 31, 2023 ($3.26M) May 14, 2024
Q2 2024 Dec 31, 2022 ($3.45M) Feb 14, 2024
Q1 2024 Sep 30, 2022 ($4.60M) Nov 13, 2023
Q3 2023 Mar 31, 2022 ($5.36M) May 11, 2023
Q2 2023 Dec 31, 2021 ($5.89M) Feb 14, 2023

Operating Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q2 2013 Dec 31, 2012 ($3.3K) Jan 18, 2013
Q1 2013 Sep 30, 2012 ($4.2K) Dec 20, 2012
Q3 2012 Mar 31, 2012 ($3.1K) Jun 5, 2012
Q2 2012 Dec 31, 2011 ($10.9K) Feb 7, 2012
Q1 2012 Sep 30, 2011 ($3.9K) Nov 10, 2011
Q3 2012 Mar 31, 2011 ($3.8K) Jun 5, 2012
Q2 2012 Dec 31, 2010 ($14.6K) Feb 7, 2012
Q1 2012 Sep 30, 2010 ($7.9K) Nov 10, 2011